Part of the problem was Bush’s Medicare D plan, which reinforced the drug companies ability to push up prices on drugs. The Canadian approach will be borrowed in the near future, to approve drugs more quickly, and increase competition.
CVS has recently introduced a generic version of the Epipen thing and it is about 1/6th of the cost… $109 vs $600+ for Epipen. That’s a start. TrumPresident and his crew will help improve this situation, but it won’t be a quick fix. The industry is entrenched on inertia in its processes and legacy costs that are still being paid off.
Part of the problem was Bush’s Medicare D plan, which reinforced the drug companies ability to push up prices on drugs. The Canadian approach will be borrowed in the near future, to approve drugs more quickly, and increase competition.
CVS has recently introduced a generic version of the Epipen thing and it is about 1/6th of the cost… $109 vs $600+ for Epipen. That’s a start. TrumPresident and his crew will help improve this situation, but it won’t be a quick fix. The industry is entrenched on inertia in its processes and legacy costs that are still being paid off.
Perhaps a good start would be to replace the head of the FDA and get someone in there that knows what they are doing.
should be ‘entrenched in inertia’. mea culpa.
I have big paws with big digits. :)
Interesting